Document Detail

Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome.
MedLine Citation:
PMID:  20188364     Owner:  NLM     Status:  MEDLINE    
In a randomized study comparing purified urinary FSH with recombinant FSH for IVF/intracytoplasmic sperm injection in patients with polycystic ovary syndrome, there was no significant difference between the mean total dose of FSH used, duration of stimulation, number of retrieved oocytes, number of mature oocytes, number of embryos transferred, or the ongoing pregnancy rate between the two groups. However, there were significantly more fertilized oocytes, a higher fertilization rate, more top-quality embryos, and more cryopreserved embryos in the urinary FSH group.
Mohamed Aboulghar; Waleed Saber; Yahia Amin; Mona Aboulghar; Ragaa Mansour; Gamal Serour
Related Documents :
11756374 - Pregnancies after oocyte donation in women with ovarian failure caused by an inactivati...
2037114 - Pregnancy after oocyte donation to a woman with ovarian failure and classical galactose...
8641494 - Premature progesterone elevation does not alter oocyte quality in in vitro fertilization.
9848314 - Repeated transmission of x-linked ocular albinism type 1 by a carrier oocyte donor.
3202414 - The value of sniff esophageal pressures in the assessment of global inspiratory muscle ...
16497694 - Abnormal placental cord insertion may induce intrauterine growth restriction in ivf-twi...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2010-02-26
Journal Detail:
Title:  Fertility and sterility     Volume:  94     ISSN:  1556-5653     ISO Abbreviation:  Fertil. Steril.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-27     Completed Date:  2010-12-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2332-4     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Department of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Fertilization in Vitro / methods*
Follicle Stimulating Hormone / adverse effects,  therapeutic use*
Infertility, Female / drug therapy*,  etiology
Ovarian Hyperstimulation Syndrome / prevention & control
Ovulation Induction / methods
Polycystic Ovary Syndrome / complications,  drug therapy*
Pregnancy Rate
Recombinant Proteins / adverse effects,  therapeutic use
Sperm Injections, Intracytoplasmic / methods
Treatment Outcome
Urofollitropin / adverse effects,  isolation & purification,  therapeutic use*
Young Adult
Reg. No./Substance:
0/Recombinant Proteins; 0/Urofollitropin; 9002-68-0/Follicle Stimulating Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Involvement of the nuclear factor-?B pathway in the pathogenesis of endometriosis.
Next Document:  Progesterone receptor-mediated up-regulation of transthyretin in preimplantation mouse uterus.